Compugen (NASDAQ: CGEN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Compugen (NASDAQ: CGEN) through any online brokerage.
There are no as such competitors for Compugen.
The latest price target for Compugen (NASDAQ: CGEN) was reported by Oppenheimer on Friday, February 25, 2022. The analyst firm set a price target for 14.00 expecting CGEN to rise to within 12 months (a possible 569.86% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Compugen (NASDAQ: CGEN) is $2.09 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Compugen.
Compugen’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for Compugen.
Compugen is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.